Amgen Inc (AMGN)
A research Signal Score of unusual activity and the signals behind it. Not advice, not a prediction, not yet backtested.
Our last 30 days of resolved calls came true 29% of the time.See the track record →
Figures reflect the most recent reported period. Margins, ROE and growth are percentages; Debt/Equity and Current ratio are ratios.
A generic 2:1 reward-to-risk example (about a 10% stop and 20% target). Illustrative and educational, not advice. Set your own levels for your risk tolerance.
- 12-month trend+37% over the past year+3
- QualityStrong net margin (23%)+7
- VolumeNo intraday volume on the free data tier — this factor is disabled, not faked.+0
Score uses live volume/momentum/breakout signals today; insider buying, short interest, options flow and social velocity layer in as those sources come online. How it works →
🤖 Dominant catalyst: competitor trial news and sector-wide biotech sentiment, not company-specific fundamentals. Continuation likelihood is moderate-to-low, as the move is driven by external headlines that may fade without fresh Amgen-specific catalysts. Informational only — not financial advice.
- A Novartis Heart Drug Trial Stumbles. Can a Rare-Disease Treatment Lift Shares?Yahoo · 2026-09-05
- NVS, IONS, AMGN Stocks Drop After-Hours — What’s Driving The Selloff?Yahoo · 2026-09-04
- Dividend Champion, Contender, And Challenger Highlights: Week September 6SeekingAlpha · 2026-09-04
- Which dow jones stocks are moving on Friday?ChartMill · 2026-09-04
- Revolution Medicines Got Its Breakthrough—What Moves It Next?Yahoo · 2026-09-04
Any AI summary is an interpretation of public news, not advice or a price target.